TGFBR1 and atrial fibrillation: Oleovitamin A and D-glucose are readily available from daily foods, they have been less studied in AF and VHD, and our molecular docking results suggest that they do not bind very strongly to TGFBR1, and thus we believe they might have less potential to treat VAF.